ITMN News 28.29 Intermune Inc (ITMN)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Intermune Inc (ITMN) 28.29 $ITMN

After Yesterday's Decline of 1.55%, InterMune Offers Investors Better Value
Comtex SmarTrend(R) - Tue Apr 15, 5:23PM CDT
InterMune (NASDAQ:ITMN) traded in a range yesterday that spanned from a low of $24.27 to a high of $28.18. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $26.26 on volume of 4.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Shares of ITMN Up 98.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 15, 9:07AM CDT
SmarTrend identified an Uptrend for InterMune (NASDAQ:ITMN) on February 12th, 2014 at $13.97. In approximately 2 months, InterMune has returned 98.78% as of today's recent price of $27.77.

Biotech Tweet of the Week: Love Being Private
Brian Orelli, The Motley Fool - Motley Fool - Mon Apr 14, 4:57PM CDT
This week's tweet of the week comes from Luke Timmerman, with a quote from Moderna Therapeutics' President and CEO Stephane Bancel, who says he loves being a private company because he has more control over what information gets released. Public...

Insider Trading Alert - ITMN, DXCM And MU Traded By Insiders
at The Street - Fri Apr 04, 10:30AM CDT
Stocks with insider trader activity include ITMN, DXCM and MU

Tradable Biotech Stocks Events For the Second Quarter
at The Street - Thu Apr 03, 8:00AM CDT
The biotech sector's March "fluctuation" might be a temporary speed bump or the beginning of a longer downturn. Either way, investors can still count on the biotech catalyst trade for chills and thrills.

Why InterMune Inc. Shares Jumped
Sean Williams, The Motley Fool - Motley Fool - Fri Mar 21, 1:36PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of InterMune , a biopharmaceutical company...

Nasdaq stocks posting largest percentage increases
AP - Fri Mar 21, 12:24PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:

Use Options For A Chance To Buy ITMN At A 53% Discount
at The Street - Fri Mar 21, 10:57AM CDT
Looking back to 8 days ago, InterMune Inc. priced a 7,500,000 share secondary stock offering at $32.75 per share.

Horizon Pharma To Buy Vidara, Join Exodus To Ireland
at Investor's Business Daily - Wed Mar 19, 9:45AM CDT
Horizon Pharma (HZNP) followed many of its fellow drugmakers to Ireland Wednesday as it agreed to buy Dublin-based Vidara Therapeutics in a deal worth $660 million. Horizon shares jumped 17% in the stock market today, hitting an all-time high....

Today’s Top Biotech Stories: Horizon Pharma, Prothena, and Portola Pharmaceuticals
Leo Sun, The Motley Fool - Motley Fool - Wed Mar 19, 8:35AM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Let's take a look at three stocks -- Horizon Pharma , ...

Better Buyout Candidate: Chelsea Therapeutics International Ltd. vs. InterMune Inc.
George Budwell, The Motley Fool - Motley Fool - Mon Mar 17, 1:30PM CDT
As more key drugs come off of patent protection, one of the central themes in biotech this year is the buyout. Companies like AstraZeneca plc and Eli Lilly , that have been deeply stricken by the so-called patent cliff, will undoubtedly be on the...

Approved Equities, Voluntary Recall, and New Product Launches - Analyst Notes on Baxter, Agilent, InterMune, Intuitive Surgical, and Mindray
PR Newswire - Fri Mar 14, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Baxter International Inc. (NYSE: BAX), Agilent Technologies Inc. (NYSE: A), InterMune Inc. (NASDAQ: ITMN), Intuitive Surgical, Inc. (NASDAQ: ISRG), and Mindray Medical International Ltd (NYSE: MR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

InterMune Announces Pricing of Public Offering of 7,500,000 Shares of Common Stock
PR Newswire - Thu Mar 13, 6:20PM CDT
InterMune, Inc. (Nasdaq: ITMN) today announced that it has agreed to sell 7,500,000 shares of its common stock at a price to the public of $32.75 per share in an underwritten public offering. InterMune has granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock in connection with the offering. InterMune estimates net proceeds from the offering to be approximately $233.0 million (assuming no exercise of the underwriters' option to purchase additional shares of common stock), after deducting underwriting discounts and estimated offering expenses. InterMune intends to use the net proceeds from the offering to fund the commercialization activities in anticipation of the potential commercial launch of Esbriet® (pirfenidone) in the United States and ongoing commercialization in Europe, to fund research and development programs with Esbriet and other compounds intended to address idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases, and for general corporate purposes. InterMune expects to close this transaction on or about March 19, 2014, subject to satisfaction of customary closing conditions.

InterMune Announces Proposed Public Offering of Common Stock
PR Newswire - Wed Mar 12, 3:02PM CDT
InterMune, Inc. (NASDAQ: ITMN) today announced that it plans to offer, subject to market and other conditions, 7,500,000 shares of its common stock in an underwritten public offering. The company expects to grant the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock in connection with the offering. All of the shares in the offering will be sold by InterMune. The shares will be issued pursuant to a prospectus supplement filed as part of a shelf registration statement previously filed with the Securities and Exchange Commission (SEC) on Form S-3.

Biotech Stock Roundup: Amgen, Regeneron Slide on PCSK9 Inhibitor Concerns - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Mar 12, 9:50AM CDT
Last week's highlights include safety concerns regarding a new class of drugs and takeover rumors.

Insider Trading Alert - ITMN, M And ILMN Traded By Insiders
at The Street - Wed Mar 12, 9:45AM CDT
Stocks with insider trader activity include ITMN, M and ILMN

, Terra Tech OTCQB TRTC Share price Grows Green up 16%
M2 - Wed Mar 12, 9:23AM CDT
March 12, 2014 Vancouver (321gostocks) -- Biotech news and Marijuana's continued rise in growing demand results in companies taking steps to advantage of strategic alliances: OSL Holdings, Inc. (OTC: OSLH), Terra Tech Corp. (OTC: TRTC), Growlife, Inc. (OTCBB: PHOT), Medical Marijuana, Inc. (OTC: MJNA) and InterMune, Inc. (NASDAQ: ITMN).

Why InterMune, Inc. Shares Rallied This Morning
Brian Pacampara, The Motley Fool - Motley Fool - Tue Mar 11, 9:26AM CDT
While Fools should generally take the opinion of Wall Street with a grain of salt, it's not a bad idea to take a look at particularly stock-shaking analyst upgrades and downgrades -- just in case their reasoning behind the call makes sense. ...

InterMune Rises on Takeover Rumor - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 4:00PM CDT
Shares of InterMune were up around 10.8% on Mar 7 to end the day's trading at $33.87

Top Gainers under the Lens: Advanced Micro Devices, Big Lots, InterMune, and Palo Alto Networks
PR Newswire - Mon Mar 10, 12:38PM CDT
The US markets saw a mixed sentiment on Friday, March 07, 2014, with the NASDAQ Composite closing at 4,336.22, down 0.37%, the Dow Jones Industrial Average ending the session at 16,452.72, up 0.19% and the S&P 500 edging 0.05% higher to finish the trading session at 1,878.04. During the session, gains in the Financials, Energy and Industrials sectors positively impacted the broader market, while some retraction came in from Health Care, Materials and Information Technology sectors. A number of stocks saw large movements, including Advanced Micro Devices Inc. (NYSE: AMD), Big Lots Inc. (NYSE: BIG), InterMune Inc. (NASDAQ: ITMN), and Palo Alto Networks Inc. (NYSE: PANW), which were amongst the top gainers for the session. Free research on these four companies can be accessed at:
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JLL’s Facility Management Push Gets a Useful Nod From Frost

Updated Category News Views 27

A Building Breaks Down Long Before the Earnings Call Notices Facility management is the sort of business that gets ignored until an airport system fails, a data-center cooling unit balks, or a workforce cannot use the building it was told to return to. That is why Frost & Sullivan’s 2026 recognition of JLL deserves more than the usual award-season shrug. It points to an...

Continue Reading
Kyndryl's Gartner Sweep Raises the Execution Bar Again

Updated Category News Views 95

A workplace help-desk ticket may sound dull as drywall, but at a giant enterprise it can become a very expensive little failure. That is why Kyndryl's latest Gartner recognition deserves more than the usual corporate backslapping. The company was named a Leader in Gartner's 2026 Magic Quadrant for Outsourced Digital Workplace Services for a third consecutive year, and...

Continue Reading
Zunyi’s History Tour Carries China’s Story Overseas

Updated Category News Views 196

China’s national story does not travel overseas by accident; it gets carried by visitors, monuments, rail lines, rivers and carefully chosen questions. The Zunyi News and Media Center report follows Tayyab, a Pakistani PhD student in aerospace engineering at Peking University, as he heads from Beijing to Zunyi, Guizhou, carrying a copy of Edgar Snow’s Red Star Over...

Continue Reading
Four Pending Deals Put Shareholder Terms Under Scrutiny

Updated Category News Views 118

Four corporate transactions landed under a legal microscope on November 18, and that is never background noise for shareholders trying to judge whether the paperwork matches the price. Halper Sadeh LLC says it is investigating proposed deals involving WaFd, Personalis, Dana and Baldwin Group for possible federal securities-law violations and/or fiduciary-duty breaches....

Continue Reading
Emaar's Huspy Deal Brings Financing Into Home Sales

Updated Category News Views 51

Mortgage paperwork is nobody’s idea of luxury, yet it can wreck a property sale faster than a bad floor plan. Emaar Properties has partnered with Dubai-based Huspy to give its customers access to mortgage advice and financing comparisons from more than 20 UAE banks. It is not a flashy tower launch or a headline-grabbing land purchase. Frankly, that is why investors...

Continue Reading
Ambition Links Call Scoring to the Coaching Room Faster

Updated Category News Views 81

A sales call dies twice when nobody turns the recording into practice. First it ends with the prospect, then it vanishes into a pile of transcripts, dashboards, and manager good intentions. Ambition’s new Call Intelligence feature is aimed squarely at that second failure. It brings Gong calls, transcripts, scorecards, and trackers into Ambition’s coaching workflow,...

Continue Reading
A €18 Million Mecca Chandelier Tests Austrian Craft

Updated Category News Views 212

Scale Is Easy to Boast About, Delivery Is Not A 34.1-metre chandelier hanging in Mecca is the sort of job that makes ordinary project talk sound downright silly. Lights of Vienna says it designed, built, tested, shipped and installed this monster for the Grand Mosque's Shamiya area, with a contract value of roughly €18 million. That is a serious piece of work for a...

Continue Reading
Pressure Injury Care Needs More Than Awareness Alone

Updated Category News Views 52

Wet skin does not care how polished the awareness campaign looks. That is the uncomfortable truth sitting underneath Worldwide Pressure Injury Prevention Day, the annual observance held on the third Thursday of November. Pressure injuries remain a stubborn problem across healthcare facilities and home care settings because prevention is not one tidy action; it is a chain...

Continue Reading
Humanoid Robots Need Results Before 2035 Hype Peaks

Updated Category News Views 245

A robot climbing stairs is neat; a robot finishing Tuesday’s shift is the investment case. The latest humanoid robotics forecast puts the global market at $3.07 billion in 2026, up from $2.26 billion in 2025, and projects $47.49 billion by 2035. That is a 35.59% compound annual growth rate, the kind of number that makes investors sit up straight. It also demands a...

Continue Reading
Star Catcher Powers a Public-Interest Space Bet Ahead

Updated Category News Views 56

A satellite’s battery budget is a rotten place for humanitarian priorities to die. Common Space and Star Catcher are trying to remove that bottleneck through a partnership that is easy to like on principle and still deserves a clear-eyed look on execution. Common Space, a nonprofit developing an independent, community-governed high-resolution satellite constellation,...

Continue Reading

Top 5 Most Recently Viewed Articles

Science Applications Intl's Earnings Preview: Key Insights Ahead

Updated Category News Views 170

Understanding Science Applications Intl's Earnings Preview Science Applications Intl (NYSE: SAIC) is gearing up for its quarterly earnings announcement. Investors are eager to see how the company performs and whether it meets analysts' expectations. What to Anticipate Analysts project Science Applications Intl will report an earnings per share (EPS) of $2.11, which could...

Continue Reading
Innovative Aerogels Paving the Path for Water Harvesting Solutions

Updated Category News Views 285

Introduction to Atmospheric Water Harvesting The world faces an alarming freshwater crisis, with projections indicating that vast segments of the population are at risk of water scarcity. In response, researchers have innovatively turned to atmospheric water harvesting, particularly highlighting the advancements made by the National University of Singapore (NUS). They...

Continue Reading
Class Action Lawsuit Alert for Tronox Holdings Plc Investors

Updated Category News Views 131

Insights into the Tronox Holdings Class Action Lawsuit Investors in Tronox Holdings Plc (NYSE: TROX) should be aware of a class action lawsuit initiated against the company. This legal action centers around allegations of potential securities fraud and improper business practices by Tronox and some of its leadership. The firm Pomerantz LLP, known for its expertise in...

Continue Reading
Rapport Therapeutics Set to Showcase Innovations in Healthcare

Updated Category News Views 128

Rapport Therapeutics to Attend Major Investor Conferences BOSTON and SAN DIEGO — Rapport Therapeutics, Inc. (Nasdaq: RAPP), a biotechnology firm at the forefront of developing small molecule precision medicines targeting neurological and psychiatric disorders, has expressed its excitement about participating in two notable investor conferences soon. Details of Upcoming...

Continue Reading
Northwestern Mutual Achieves Unmatched Financial Strength Ratings

Updated Category News Views 353

Northwestern Mutual Achieves Elite Financial Ratings for 35 Years For an impressive 35 years, Northwestern Mutual has consistently earned top financial strength ratings from the nation's leading rating agencies. This recognition underscores the company’s commitment to maintaining a robust financial foundation, which plays a crucial role in their ability to serve clients...

Continue Reading